Retinal gene expression after central retinal artery ligation: Effects of ischemia and reperfusion

Investigative Ophthalmology and Visual Science

Volumn 51, Issue 12, 2010, Pages 6207-6219

  Prasad, Shiv S ^a   Kojic, Ljubomir ^b,c   Wen, Yan H ^b,c   Chen, Zheng ^b,c   Xiong, Wei ^b,c   Jia, William ^b,c   Cynader, Max S ^b,c  

^a HEALTH CANADA   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CASPASE 9;

AKT1 GENE; AKT3 GENE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATF3 GENE; BTG2 GENE; CASPASE 3 GENE; CASPASE 7 GENE; CASPASE 9 GENE; CELL LOSS; CENTRAL RETINA ARTERY OCCLUSION; CONTROLLED STUDY; DOWN REGULATION; GENE; GENE ACTIVATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE FUNCTION; GENETIC TRANSCRIPTION; GLUCONEOGENESIS; GLYCOLYSIS; ID2 GENE; KLF4 GENE; MALE; MOLECULAR PATHOLOGY; NONHUMAN; ONCOGENE C FOS; ONCOGENE C JUN; PIK3R1 GENE; PRIORITY JOURNAL; PRKCB1 GENE; RAT; REPERFUSION; RETINA BIPOLAR GANGLION CELL; RETINA ISCHEMIA; TP53 GENE; UPREGULATION;

ANIMALS; APOPTOSIS REGULATORY PROTEINS; EYE PROTEINS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; IN SITU NICK-END LABELING; ISCHEMIA; LIGATION; MALE; NUCLEIC ACID HYBRIDIZATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RATS; RATS, INBRED LEW; REPERFUSION INJURY; RETINA; RETINAL ARTERY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTION FACTORS;

EID: 79955603892     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.10-5632     Document Type: Article

References (79)

1. Rudkin AK, Lee AW, Chen CS. Central retinal artery occlusion: timing and mode of presentation. Eur J Neurol. 2009;16:674-677.
2. Jenkins HS, Marcus DF. Central retinal artery occlusion. JACEP. 1979;8:363-367.
3. Glacet-Bernard A, Meunier I. [Vascular diseases of the retina]. Rev Prat. 1996;46:1737-1743
4. Kogure S, Iijima H. Retinal arterial obstruction and systemic disorders. Nippon Ganka Gakkai Zasshi. 1991;95:67-72.
5. Douglas DJ, Schuler JJ, Buchbinder D, Dillon BC, Flanigan DP. The association of central retinal artery occlusion and extracranial carotid artery disease. Ann Surg. 1988;208:85-90.
6. Osborne NN, Ugarte M, Chao M, et al. Neuroprotection in relation to retinal ischemia and relevance to glaucoma. Surv Ophthalmol. 1999;43:S102-S128.
7. Bien A, Seidenbecher CI, Bockers TM, Sabel BA, Kreutz MR. Apoptotic versus necrotic characteristics of retinal ganglion cell death after partial optic nerve injury. J Neurotrauma. 1999;16:153-163.
8. Clemens JA. Cerebral ischemia: gene activation, neuronal injury, and the protective role of antioxidants. Free Radic Biol Med. 2000;28:1526-1531.
9. Dkhissi O, Chanut E, Wasowicz M, et al. Retinal TUNEL-positive cells and high glutamate levels in vitreous humor of mutant quail with a glaucoma-like disorder. Invest Ophthalmol Vis Sci. 1999; 40:990-995.
10. Egan RA, Biousse V. Update on ischemic stroke. Curr Opin Ophthalmol. 2000;11:395-402.
11. Gehlbach PL, Purple RL. A paired comparison of two models of experimental retinal ischemia. Curr Eye Res. 1994;13:597-602.
12. Isenmann S, Wahl C, Krajewski S, Reed JC, Bahr M. Up-regulation of Bax protein in degenerating retinal ganglion cells precedes apoptotic cell death after optic nerve lesion in the rat. Eur J Neurosci. 1997;9:1763-1772.
13. Joo CK, Choi JS, Ko HW, et al. Necrosis and apoptosis after retinal ischemia: involvement of NMDA-mediated excitotoxicity and p53. Invest Ophthalmol Vis Sci. 1999;40:713-720.
14. Kaneda K, Kashii S, Kurosawa T, et al. Apoptotic DNA fragmentation and upregulation of Bax induced by transient ischemia of the rat retina. Brain Res. 1999;815:11-20.
15. Katai N, Yoshimura N. Apoptotic retinal neuronal death by ischemia- reperfusion is executed by two distinct caspase family proteases. Invest Ophthalmol Vis Sci. 1999;40:2697-2705.
16. Piltz-Seymour JR, Grunwald JE, Hariprasad SM, Dupont J. Optic nerve blood flow is diminished in eyes of primary open-angle glaucoma suspects. Am J Ophthalmol. 2001;132:63-69.
17. Quigley HA, Nickells RW, Kerrigan LA, Pease ME, Thibault DJ, Zack DJ. Retinal ganglion cell death in experimental glaucoma andafter axotomy occurs by apoptosis. Invest Ophthalmol Vis Sci. 1995;36:774-786.
18. Quigley HA, Katz J, Derick RJ, Gilbert D, Sommer A. An evaluation of optic disc and nerve fiber layer examinations in monitoring progression of early glaucoma damage. Ophthalmology. 1992;99: 19-28.
19. Sommer A, Katz J, Quigley HA, et al. Clinically detectable nerve fiber atrophy precedes the onset of glaucomatous field loss. Arch Ophthalmol. 1991;109:77-83.
20. Osborne NN, Melena J, Chidlow G, Wood JP. A hypothesis to explain ganglion cell death caused by vascular insults at the optic nerve head: possible implication for the treatment of glaucoma. Br J Ophthalmol. 2001;85:1252-1259.
21. Robin AL, Barnebey HS, Harris A, Osborne NN. Glaucoma management: beyond intraocular pressure. Ophthalmol Times. 1997;23.
22. Kohner EM. Diabetic retinopathy. Br Med Bull. 1989;45:148-173
23. Mattson MP, Duan W, Pedersen WA, Culmsee C. Neurodegenerative disorders and ischemic brain diseases. Apoptosis. 2001;6:69-81.
24. Rosenbaum DM, Rosenbaum PS, Gupta A, Michaelson MD, Hall DH, Kessler JA. Retinal ischemia leads to apoptosis which is ameliorated by aurintricarboxylic acid. Vision Res. 1997;37:3445-3451.
25. Rosenbaum DM, Rosenbaum PS, Singh M, et al. Functional and morphologic comparison of two methods to produce transient retinal ischemia in the rat. J Neuroophthalmol. 2001;21:62-68.
26. Sucher NJ, Lipton SA, Dreyer EB. Molecular basis of glutamate toxicity in retinal ganglion cells. Vis Res. 1997;37:3483-3493.
27. Luo X, Lambrou GN, Sahel JA, Hicks D. Hypoglycemia induces general neuronal death, whereas hypoxia and glutamate transport blockade lead to selective retinal ganglion cell death in vitro. Invest Ophthalmol Vis Sci. 2001;42:2695-2705.
28. Adachi K, Kashii S, Masai H, et al. Mechanism of the pathogenesis of glutamate neurotoxicity in retinal ischemia. Graefe's Arch ClinExp Ophthalmol. 1998;236:766-774.
29. Rumelt S, Brown GC. Update on treatment of retinal arterial occlusions. Curr Opin Ophthalmol. 2003;14:139-141.
30. Hughes WF. Quantitation of ischemic damage in the rat retina. Exp Eye Res. 1991;53:573-582.
31. Larsen AK, Osborne NN. Involvement of adenosine in retinal ischemia: studies on the rat. Invest Ophthalmol Vis Sci. 1996;37: 2603-2611.
32. Buchi ER. Cell death in rat retina after pressure-induced ischaemiareperfusion insult: electron microscopic study, II: outer nuclear layer. Jpn J Ophthalmol. 1992;36:62-68.
33. Buchi ER, Suivaizdis I, Fu J. Pressure-induced retinal ischemia in rats: an experimental model for quantitative study. Int J Ophthalmol. 1991;203:138-147.
34. Osborne NN, Larsen A, Barnett NL. Influence of excitatory amino acids and ischemia on rat retinal choline acetyltransferase-containing cells. Invest Ophthalmol Vis Sci. 1995;36:1692-1700.
35. Safa R, Osborne NN. Retinas from albino rats are more susceptible to ischaemic damage than age-matched pigmented animals. Brain Res. 2000;862:36-42.
36. Cheon EW, Park CH, Kang SS, et al. Change in endothelial nitric oxide synthase in the rat retina following transient ischemia. Neuroreport. 2003;14:329-333.
37. Melena J, Safa R, Graham M, Casson RJ, Osborne NN. The monocarboxylate transport inhibitor, alpha-cyano-4-hydroxycinnamate, has no effect on retinal ischemia. Brain Res. 2003;989:128-134.
38. Leahy KM, Ornberg RL, Wang Y, et al. Quantitative ex vivo detection of rodent retinal ganglion cells by immunolabeling Brn-3b. Exp Eye Res. 2004;79:131-140.
39. Bucolo C, Drago F. Effects of neurosteroids on ischemia-reperfusion injury in the rat retina: role of sigma1 recognition sites. Eur J Pharmacol. 2004;498:111-114.
40. Roth S, Li B, Rosenbaum PS, et al. Preconditioning provides complete protection against retinal ischemic injury in rats. Invest Ophthalmol Vis Sci. 1998;39:777-785.
41. Stefansson E, Wilson CA, Schoen T, Kuwabara T. Experimental ischemia induces cell mitosis in the adult rat retina. Invest Ophthalmol Vis Sci. 1988;29:1050-1055.
42. Li B, Roth S. Retinal ischemic preconditioning in the rat: requirement for adenosine and repetitive induction. Invest Ophthalmol Vis Sci. 1999;40:1200-1216.
43. Li B, Pang IH, Barnes G, McLaughlin M, Holt W. A new method and device to induce transient retinal ischemia in the rat. Curr Eye Res. 2002;24:458-464.
44. Morrison JC, Johnson EC, Cepurna WO, Funk RH. Microvasculature of the rat optic nerve head. Invest Ophthalmol Vis Sci. 1999;40:1702-1709.
45. Sugiyama K, Gu ZB, Kawase C, Yamamoto T, Kitazawa Y. Optic nerve and peripapillary choroidal microvasculature of the rat eye. Invest Ophthalmol Vis Sci. 1999;40:3084-3090.
46. Albrecht May C. Comparative anatomy of the optic nerve head and inner retina in non-primate animal models used for glaucoma research. Open Ophthalmol J. 2008;2:94-101.
47. Zhang Y, Cho CH, Atchaneeyasakul LO, McFarland T, Appukuttan B, Stout JT. Activation of the mitochondrial apoptotic pathway in a rat model of central retinal artery occlusion. Invest Ophthalmol Vis Sci. 2005;46:2133-2139.
48. Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A. 2001;98:5116-5121.
49. Bolstad BM, Irizarry RA, Astrand M, Speed TP. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics. 2003;19:185-193.
50. Subramanian A, Kuehn H, Gould J, Tamayo P, Mesirov JP. GSEA-P: a desktop application for Gene Set Enrichment Analysis. Bioinformatics. 2007;23:3251-3253.
51. Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genomewide expression profiles. Proc Natl Acad Sci U S A. 2005;102: 15545-15550.
52. Mootha VK, Lindgren CM, Eriksson KF, et al. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet. 2003;34:267-273.
53. Talaat AM, Howard ST, Hale W, Lyons R, Garner H, Johnston SA. Genomic DNA standards for gene expression profiling in Mycobacterium tuberculosis. Nucleic Acids Res. 2002;30:e104
54. Ramaswamy S, Ross KN, Lander ES, Golub TR. A molecular signature of metastasis in primary solid tumors. Nat Genet. 2003;33:49-54.
55. Kamphuis W, Dijk F, Bergen AA. Ischemic preconditioning alters the pattern of gene expression changes in response to full retinal ischemia. Mol Vis. 2007;13:1892-1901.
56. Kamphuis W, Dijk F, van Soest S, Bergen AA. Global gene expression profiling of ischemic preconditioning in the rat retina. Mol Vis. 2007;13:1020-1030.
57. Kelai S, Maussion G, Noble F, et al. Nrxn3 upregulation in the globus pallidus of mice developing cocaine addiction. Neuroreport. 2008;19:751-755.
58. Chen CS, Miller NR. Ocular ischemic syndrome: review of clinical presentations, etiology, investigation, and management. Compr Ophthalmol Update. 2007;8:17-28.
59. Rumelt S, Dorenboim Y, Rehany U. Aggressive systematic treatment for central retinal artery occlusion. Am J Ophthalmol. 1999; 128:733-738.
60. The Amaurosis Fugax Study Group. Current management of amaurosis fugax: the Amaurosis Fugax Study Group. Stroke. 1990;21: 201-208.
61. Ju WK, Lee MY, Hofmann HD, Kirsch M, Chun MH. Expression of CNTF in Muller cells of the rat retina after pressure-induced ischemia. Neuroreport. 1999;10:419-422.
62. Tezel G, Wax MB. Inhibition of caspase activity in retinal cell apoptosis induced by various stimuli in vitro. Invest Ophthalmol Vis Sci. 1999;40:2660-2667.
63. Kuroiwa S, Katai N, Shibuki H, et al. Expression of cell cyclerelated genes in dying cells in retinal ischemic injury. Invest Ophthalmol Vis Sci. 1998;39:610-617.
64. Yoshimura N, Kikuchi T, Kuroiwa S, Gaun S. Differential temporal and spatial expression of immediate early genes in retinal neurons after ischemia-reperfusion injury. Invest Ophthalmol Vis Sci. 2003; 44:2211-2220.
65. Dijk F, van Leeuwen S, Kamphuis W. Differential effects of ischemia/reperfusion on amacrine cell subtype-specific transcript levels in the rat retina. Brain Res. 2004;1026:194-204.
66. Dijk F, Kraal-Muller E, Kamphuis W. Ischemia-induced changes of AMPA-type glutamate receptor subunit expression pattern in the rat retina: a real-time quantitative PCR study. Invest Ophthalmol Vis Sci. 2004;45:330-341.
67. Kamphuis W, Dijk F, Kraan W, Bergen AA. Transfer of lens-specific transcripts to retinal RNA samples may underlie observed changes in crystallin-gene transcript levels after ischemia. Mol Vis. 2007; 13:220-228.
68. Blackshaw S, Harpavat S, Trimarchi J, et al. Genomic analysis of mouse retinal development. PLoS Biol. 2004;2:E247.
69. Dorrell MI, Aguilar E, Weber C, Friedlander M. Global gene expression analysis of the developing postnatal mouse retina. Invest Ophthalmol Vis Sci. 2004;45:1009-1019.
70. Thiersch M, Raffelsberger W, Frigg R, et al. Analysis of the retinal gene expression profile after hypoxic preconditioning identifies candidate genes for neuroprotection. BMC Genomics. 2008;9:73.
71. Grimm C, Hermann DM, Bogdanova A, et al. Neuroprotection by hypoxic preconditioning: HIF-1 and erythropoietin protect from retinal degeneration. Semin Cell Dev Biol. 2005;16:531-538.
72. Whitlock NA, Agarwal N, Ma JX, Crosson CE. Hsp27 upregulation by HIF-1 signaling offers protection against retinal ischemia in rats. Invest Ophthalmol Vis Sci. 2005;46:1092-1098.
73. Sakamoto K, Yonoki Y, Kubota Y, et al. Inducible nitric oxide synthase inhibitors abolished histological protection by late ischemic preconditioning in rat retina. Exp Eye Res. 2006;82: 512-518.
74. Yoshida S, Yashar BM, Hiriyanna S, Swaroop A. Microarray analysis of gene expression in the aging human retina. Invest Ophthalmol Vis Sci. 2002;43:2554-2560.
75. Coschigano KT, Holland AN, Riders ME, List EO, Flyvbjerg A, Kopchick JJ. Deletion, but not antagonism, of the mouse growth hormone receptor results in severely decreased body weights, insulin, and insulin-like growth factor I levels and increased life span. Endocrinology. 2003;144:3799-3810.
76. Miskin R, Masos T, Yahav S, Shinder D, Globerson A. MUPA mice: a transgenic model for increased life span. Neurobiol Aging. 1999; 20:555-564.
77. Choudhury AR, Ju Z, Djojosubroto MW, et al. Cdkn1a deletion improves stem cell function and lifespan of mice with dysfunctional telomeres without accelerating cancer formation. Nat Genet. 2007;39:99-105.
78. Yang Z, Quigley HA, Pease ME, et al. Changes in gene expression in experimental glaucoma and optic nerve transection: the equilibrium between protective and detrimental mechanisms. Invest Ophthalmol Vis Sci. 2007;48:5539-5548.
79. Cantley LC. The phosphoinositide 3-kinase pathway. Science. 2002;296:1655-1657.